Ole Frobert

Professor

Aarhus University

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ole Frobert is a Professor at Aarhus University in Denmark. His research areas focus on cardiovascular health, particularly the effectiveness of medications in myocardial infarction, the implications of vascular health indicators, and innovative management strategies for heart failure. His recent publications explore long-term outcomes after coronary interventions and the interrelationship between inflammation and cardiovascular protection.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Karen Gjesing Welinder

Professor emeritus

Aalborg University

DENMARK

View details

Si Fang

Karolinska Institutet

SWEDEN

View details

Anne Mette Frøbert

Aalborg University

DENMARK

View details

henning kelbæk

Chief physician

Zealand University Hospital

DENMARK

View details

Hans Erik Bøtker

Aarhus University

DENMARK

View details

Tomas Jernberg

Karolinska Institutet

SWEDEN

View details

Matthias Götberg

SWEDEN

View details

Michael Toft Overgaard

Professor

Aalborg University

DENMARK

View details

David Erlinge

Lund University

SWEDEN

View details

Jacob A. Udell

CANADA

View details

Sacharias von Koch

Lund University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ole Frobert

Research Interests

Contact this professor

About

Articles (17)

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI

Long-term prognosis after coronary bifurcation PCI-A nationwide observational study

Long-term effectiveness of ACE inhibitors or angiotensin receptor blockers in myocardial infarction with preserved left ventricular ejection fraction

The flu shot and cardiovascular Protection: Rethinking inflammation in ischemic heart disease

Impact of Lipidic Plaque on In-Stent and Stent Edge–Related Events After PCI in Myocardial Infarction: A PROSPECT II Substudy

The potential of wearable sweat sensors in heart failure management

Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Flow Reserve

Paper II: Thematic framework analysis of registry-based randomized controlled trials provided insights for designing trial ready registries

The ideal vaccine to prevent cardiovascular disease

Clinical Outcome of Revascularization Deferral With Instantaneous Wave‐Free Ratio and Fractional Flow Reserve: A 5‐Year Follow‐Up Substudy From the iFR‐SWEDEHEART Trial

Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction - insights from the IAMI trial

Circulating insulin-like growth factor system adaptations in hibernating brown bears indicate increased tissue IGF availability

Plasma proteomics data from hibernating and active Scandinavian brown bears

Characterization and comparison of recombinant full‐length ursine and human sex hormone‐binding globulin

Fractional Flow Reserve—Dichotomous Decisions in Myocardial Ischemia

Reporting transparency and completeness in trials: Paper 3 – trials conducted using administrative databases do not adequately report elements related to use of databases

Collaborators (11)

Karen Gjesing Welinder

Si Fang

Anne Mette Frøbert

henning kelbæk

Hans Erik Bøtker

Tomas Jernberg

Matthias Götberg

Michael Toft Overgaard

David Erlinge

Jacob A. Udell

Sacharias von Koch

Make your next move.